A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new ...

Several weeks after NBC News reached out to Anthem Blue Cross Blue Shield about the denial, the insurer changed its policy to ...

New research suggests that paralyzed patients could regain some degree of movement — perhaps even walk again. In a study led by EPFL (Swiss Federal Technology Institute of Lausanne) and Lausanne ...

7NEWS cameras were inside the clinic to witness the moment Walter Grkovic became the first patient in Australia to receive adaptive deep brain stimulation to treat Parkinson’s disease. “It’s great, ...

Abbott has launched a pivotal clinical trial to see if its deep-brain stimulation approach can make headway against treatment-resistant depression. The company previously collected green lights for ...

Deep brain stimulation can significantly reduce depressive symptoms in some individuals. Knowing what to expect before and after the procedure may help you determine if it’s right for you. Deep brain ...

Deep brain stimulation (DBS) involves stimulating certain parts of your brain with implanted electrodes. It’s a promising treatment for treatment-resistant OCD. The main treatments for OCD are talk ...

Device-based neuromodulation therapies may offer a viable alternative for patients with depression who do not achieve adequate response to SSRIs.

At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows. Rates of treatment response and depression remission were three times ...

A new study shows that a personalized, precise form of brain stimulation, HD-tDCS, can rapidly ease depression symptoms – and even reduce anxiety – offering a promising drug-free alternative with only ...

Brain injury often causes balance and gait impairments. Neuromodulation offers a noninvasive, time-limited way to restore or significantly improve balance.

Decades of agonizing delays in major depressive disorder treatment may finally be coming to an end, as two pivotal studies—a February 2026 clinical evaluation from the University of California, Los ...